David Youssef, MD
Pain Medicine · Newton, NJNPI 1164918942
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $10,185 with a category attached, or 98.2%. Medtronic accounts for 99.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $10,078 and has fallen 99.8% since, to $15 in 2025. Among pain medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $1273.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Stryker$24
- Johnson & Johnson$24
- Fidia Pharma USA Inc.$20
- Globus Medical$15
What the payments were for
- Grants$10,00098%
- Food & beverage$1852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $10,101 |
| Stryker | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Globus Medical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$10,000
How this compares
$10,185 in reported general payments places this provider in the 90th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 93 | $1,526 |
| Pregabalin | 57 | $1,335 |
| Oxycodone Hcl | 99 | $1,184 |
| Tramadol Hcl | 121 | $932 |
| Tramadol Hcl ErTramadol Hcl | 11 | $839 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 57 | $770 |
| Celecoxib | 58 | $643 |
| Baclofen | 14 | $377 |
| Tizanidine Hcl | 54 | $225 |
| Meloxicam | 58 | $183 |
| Hydromorphone Hcl | 20 | $178 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 40 | $172 |
| Prednisone | 53 | $142 |
| Diclofenac Sodium | 11 | $135 |
| Methylprednisolone | 26 | $132 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Newton
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
- Matthew LesneskiMount Laurel$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.